Back

Identification and determination of the AST pattern of Acinetobacter species isolated from different clinical samples by VITEK circled2 Compact

DIXIT, S.

2026-03-10 infectious diseases
10.64898/2026.03.07.26347849 medRxiv
Show abstract

IntroductionAcinetobacter is a highly diverse genus which includes a range of common pathogenic species such as A. baumannii, A. lwoffii etc. Acinetobacter species causes bacteremia, pneumonia, wound infections, Urinary tract infections in community as well as hospital settings. A. baumannii is one of the ESKAPE pathogen which makes it even more lethal as antibiotics cannot action on this. AimTo isolate Acinetobacter species from various clinical samples and to check their antimicrobial susceptibility pattern by VITEK {square} Compact in SGT Hospital, Gururam, Haryana. ResultsOut of total 6673 samples 595 were the positive isolates from which 35 were Acinetobacter isolates which were received from various wards of the hospital. Occurrence of Acinetobacter was seen more in males(57.14%) as compare to females (46.8%). A total of 31 strains were A. baumannii, 3 were A. lwoffi and 1 strain was of A. haemolyticus. Prominent presence of Acinetobacter was seen in Blood (48.57%) specimen along with pus(22.85%), endotracheal (22.85%), tracheal (2.85%) and eye swabs (2.85%). All the isolates were resistant to piperacillin/tazobactam (100%), ceftriazone (100%), amikacin (100%), gentamicin (100%) ciprofloxacin (91.42%), ceftazidime (91.42%), cefepime (88.57%), levofloxacin (88.57%) and trimethoprim/sulfamethoxazole (80%). Colistin susceptibility was observed in 88.57% of the isolates. ConclusionAcinetobacter is a common pathogen in hospital acquired as well as in community acquired infections as it is a opportunistic pathogen hence to identify the Acinetobacter species and to understand their antimicrobial resistance pattern this study was conducted.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 14%
14.0%
2
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 0.2%
9.9%
3
Access Microbiology
22 papers in training set
Top 0.1%
4.1%
4
Journal of Medical Microbiology
20 papers in training set
Top 0.1%
3.9%
5
Journal of Global Antimicrobial Resistance
15 papers in training set
Top 0.1%
3.9%
6
Journal of Medical Virology
137 papers in training set
Top 0.8%
3.9%
7
BMC Infectious Diseases
118 papers in training set
Top 1%
3.5%
8
JAC-Antimicrobial Resistance
13 papers in training set
Top 0.1%
3.5%
9
International Journal of Antimicrobial Agents
15 papers in training set
Top 0.1%
3.5%
50% of probability mass above
10
Scientific Reports
3102 papers in training set
Top 40%
3.2%
11
BMC Microbiology
35 papers in training set
Top 0.2%
3.0%
12
Journal of Hospital Infection
27 papers in training set
Top 0.2%
2.0%
13
Journal of Clinical Microbiology
120 papers in training set
Top 0.8%
2.0%
14
Journal of Family Medicine and Primary Care
10 papers in training set
Top 0.2%
2.0%
15
Pathogens
53 papers in training set
Top 0.6%
1.7%
16
Cureus
67 papers in training set
Top 3%
1.7%
17
Frontiers in Microbiology
375 papers in training set
Top 6%
1.6%
18
Journal of Antimicrobial Chemotherapy
43 papers in training set
Top 0.3%
1.5%
19
Journal of Infection
71 papers in training set
Top 2%
1.5%
20
F1000Research
79 papers in training set
Top 2%
1.5%
21
Journal of Clinical Virology
62 papers in training set
Top 0.5%
1.2%
22
Antibiotics
32 papers in training set
Top 1.0%
1.2%
23
PLOS Neglected Tropical Diseases
378 papers in training set
Top 4%
0.9%
24
PLOS Global Public Health
293 papers in training set
Top 5%
0.9%
25
Heliyon
146 papers in training set
Top 5%
0.9%
26
Microorganisms
101 papers in training set
Top 2%
0.9%
27
Archives of Clinical and Biomedical Research
28 papers in training set
Top 2%
0.8%
28
Archives of Microbiology
11 papers in training set
Top 0.4%
0.8%
29
Infection, Genetics and Evolution
43 papers in training set
Top 0.9%
0.8%
30
BioMed Research International
25 papers in training set
Top 3%
0.8%